Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Up – Still a Buy?

Anbio Biotechnology (NASDAQ:NNNN)’s stock price gapped up prior to trading on Tuesday . The stock had previously closed at $10.19, but opened at $10.64. Anbio Biotechnology shares last traded at $10.7250, with a volume of 759 shares traded.

Wall Street Analyst Weigh In

Separately, Weiss Ratings cut shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, July 29th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has an average rating of “Sell”.

Anbio Biotechnology Price Performance

The business has a fifty day moving average of $13.67.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.